Balchem Corporation (FRA:BL9B)

Market Cap	4.64B +11.1%
Revenue (ttm)	950.47M +10.1%
Net Income	143.91M +15.2%
EPS	4.45 +16.5%
Shares Out	n/a
PE Ratio	32.27
Forward PE	27.31
Dividend	0.82 (0.59%)
Ex-Dividend Date	Dec 23, 2025

Volume	n/a
Open	144.00
Previous Close	139.70
Day's Range	139.10 - 144.00
52-Week Range	118.60 - 154.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About Balchem

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended ...

• Industry: Industrial Organic Chemicals
• Founded: 1967
• Employees: 1,379
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BL9B

Financial Performance

In 2025, Balchem's revenue was $1.04 billion, an increase of 8.75% compared to the previous year's $953.68 million. Earnings were $154.85 million, an increase of 20.53%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 18, 2026

Data Sources Report a data error